Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» EMA
EMA
EMA Backs Eight New Medicines, Turns Down Drugs From Nektar & Vanda
RAPS.org
Sat, 07/22/17 - 12:23 pm
EMA
Europe
Pfizer
Bavencio
Novartis
Rydapt
Lexicon Pharmaceuticals
Xermelo
Vanda
Fanaptum
Nektar
Onzeald
Daiichi Sankyo
EMA Restricts Use of Biogen MS Drug
RAPS.org
Sun, 07/9/17 - 11:39 am
Europe
EMA
Biogen
MS
multiple sclerosis
Zinbryta
EMA Recommends New HCV, Cancer and MS Drugs for Approval
RAPS.org
Sat, 06/24/17 - 09:11 am
Europe
EMA
hepatitis C
multiple sclerosis
breast cancer
renal cell carcinoma
AbbVie
Maviret
Gilead Sciences
Vosevi
Biogen
Amgen
Samsung Bioepis
biosimilars
Humira
Novartis
Kisqali
EUSA
Fotivda
Novo Nordisk files to add Lantus-matching CV data to Tresiba's European label
Fierce Pharma
Fri, 06/16/17 - 09:35 am
Novo Nordisk
Lantus
Tresiba
diabetes
Europe
EMA
insulin
EMA recommends 11 drugs for approval in May meeting
BioPharma Dive
Thu, 05/25/17 - 09:26 am
EMA
Europe
Sanofi
AstraZeneca
LEO Pharma
Novartis
Pfizer
Sanofi’s insulin biosimilar wins EMA committee recommendation
Drug Delivery Business News
Mon, 05/22/17 - 09:36 am
Sanofi
insulin
biosimilars
EMA
Europe
Lispro
EU drugmakers urge June decision on new location for watchdog
Yahoo/Reuters
Mon, 04/24/17 - 10:01 am
Europe
EMA
Brexit
EMA panel recommends nod for Sanofi, Regeneron's arthritis drug
Yahoo/Reuters
Sat, 04/22/17 - 01:14 pm
Europe
EMA
Sanofi
Regeneron
rheumatoid arthritis
Kevzara
Sarilumab
Boehringer Ingelheim's Humira Biosimilar Under Review by EMA, FDA
Yahoo/GuruFocus
Fri, 01/20/17 - 09:45 am
Boehringer Ingelheim
Humira
biosimilars
FDA
EMA
BI 695501
AbbVie
Bristol-Myers Squibb Reveals Regulatory Approvals For Opdivo Marketing Application
Yahoo/Benzinga
Mon, 07/18/16 - 11:07 am
Bristol-Myers Squibb
Opdivo
squamous cell carcinoma of the head and neck
FDA
EMA
EMA removes warning from Pfizer smoking cessation drug
BioPharma Dive
Mon, 05/23/16 - 10:15 am
Pfizer
smoking cessation
Europe
EMA
Champix
Chantix
EMA chief: Faster drug approvals can quell Rx sticker shock
BioPharma Dive
Thu, 12/10/15 - 11:08 am
Europe
drug approvals
EMA
EMA Recommends Hundreds of Drugs to be Suspended Over ‘Flawed Studies’
WSJ Pharmalot
Fri, 01/23/15 - 10:31 am
EMA
Europe
Should FDA and EMA Team up to Approve Drugs on a Reciprocal Basis?
Regulatory Focus
Wed, 02/19/14 - 08:57 am
FDA
drug approvals
Europe
EMA
EMA Bests FDA in 2013 New Drug Approval Numbers
Fierce Biotech
Wed, 01/22/14 - 10:40 am
EMA
FDA
drug approvals
European Drug Agency Delays Trial-Data Policy Until March
Bloomberg
Tue, 12/17/13 - 02:36 pm
clinical trial data
EMA
Europe
Pharma Blasts EMA Draft Policy On Disclosing Clinical Trial Data
Pharmalot
Mon, 09/9/13 - 10:40 am
clinical trial data
clinical trials
EMA
Simultaneous Applications Submitted to EMA and FDA for Siltuximab for the Treatment of Multicentric Castleman Disease, a Rare Blood Disorder
Reuters
Tue, 09/3/13 - 10:43 am
EMA
FDA
siltuximab
multicentric Castleman disease
AbbVie seeks to stop EU agency releasing drug data
Reuters
Mon, 03/11/13 - 10:46 am
AbbVie
drug data
EMA
Europe
Novartis gets EMA nod for Jetrea
FiercePharma
Sat, 01/19/13 - 12:14 pm
Novartis
EMA
Jetrea
regulatory
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »